WFC — Wells Fargo & Company

The tape and the analyst community are telling different stories as of 2026-10-14. The tape is soft: -11.12% over one month, -9.90% over three months, RSI 35.55, and price below all three major moving averages. The analysts are constructive: 28 Buy vs 28 Hold vs 4 Sell, consensus rating 'Buy', and a consensus target near $98 against a $78.73 price. The Q3 2026 report (filed 2026-10-13) delivered EPS of $1.87 vs ~$1.85 consensus and roughly 13% YoY earnings growth on the company's framing, but total revenue of ~$21.87B missed the ~$22.31B expectation, which is what triggered the pullback. Individual target moves were mixed - KBW trimmed to $90 on net interest margin mechanics, Truist raised to $95 - i.e., analysts like the franchise but are marking down top-line mechanics.

Three-year arc from the FMP quarterly series: revenue bottomed at $29.63B in Q1 2025 and has climbed to $33.26B in Q3 2026, with YoY growth running +7.3% (Q1 2026), +11.3% (Q2 2026) and then +4.2% (Q3 2026) - so the top line is growing but decelerating, and the Q2 2026 spike ($33.59B, +11.3% YoY) looks more like a high-water mark than the new run-rate. Earnings quality is better: diluted EPS went from $0.86 in Q4 2023 (a quarter depressed by the FDIC special assessment) to a $1.20-$1.43 range through 2024, $1.39-$1.67 through 2025, and $1.60/$2.00/$1.87 in Q1-Q3 2026, i.e., consistent low-to-mid-teens YoY growth in each of the last four quarters. Operating margin tells the same story of structural repair: 11.2% in Q4 2023, 17.6-19.7% through 2024, and 18.0-24.0% through 2025-2026, though Q3 2026's 21.3% was down sequentially from Q2 2026's 24.0%. Net margin TTM is 17.6%. The blip to flag is sequential softening in Q3 2026 (revenue -1.0% QoQ, operating income -11.8% QoQ); the structural trend to note is a bank earning meaningfully more per dollar of revenue than it did three years ago. Balance sheet: total assets grew from $1.93T (Q4 2023) to $2.25T (Q3 2026), +16.7%, while common equity actually fell from $185.7B to $175.8B - buybacks plus AOCI, which mechanically flatters ROE.

Modestly cheap versus its own history, not deep value. As of 2026-10-14, WFC's trailing P/E was 10.90 against a 5-year average of 12.05 (~10% discount), and forward P/E on the $7.329 next-FY consensus EPS is roughly 10.7x. PEG of 0.63 and P/S of 1.83 vs a 5-year average of 2.02 reinforce the same picture. P/B is 1.351x against an 11.8% ROE and a 16.3% ROTCE reported in Q3 2026 - you are paying a little over book for a franchise currently earning near its multi-year best return on tangible capital and targeting 17-18%. Dividend yield of 2.12% is a real component of return. The catch: a ~4% revenue grower with flat NII guidance (~$50B for 2026, ~$13B for Q4) does not deserve a premium multiple, so the discount is earned rather than an obvious mispricing.

At $78.73 against ~$7.33 of next-FY consensus EPS, the market is paying about 10.7x for a bank guiding to roughly flat net interest income and mid-single-digit revenue growth - in other words, it is pricing in skepticism about the top line, not a collapse. The Q3 2026 setup is instructive: a clean EPS beat ($1.87 vs ~$1.85) got sold because revenue missed. That tells you the marginal buyer cares about NII and the efficiency ratio far more than about buyback-driven EPS. Two paths from here: if Q4 NII lands near the guided ~$13B and ROTCE keeps grinding from 16.3% toward the 17-18% target, EPS estimates hold and a re-rating to the 5-year average multiple of ~12x gets you to roughly $88-90. If deposit costs keep squeezing NIM and revenue growth stays around 4%, estimates drift down and the multiple stays stuck at 10-11x, which caps the stock near $75-80 regardless of EPS. The stock is not pricing in a growth story that hasn't shown up; it is pricing in roughly the growth that has shown up, which means the upside case requires the NII trajectory to improve, not just continued execution.

Weak, but approaching a level where mean-reversion buyers historically show up. As of 2026-10-14, RSI(14) was 35.55 - near oversold, not in it - with price 4.05% below the 20-day SMA, 7.63% below the 50-day and 6.43% below the 200-day. Being below all three averages in that order is a clean downtrend, and the -11.12% one-month return confirms momentum is negative. The offset is that $78.73 sits only about 8% above the 52-week low of $72.78, a level that has caught bids this year. Entry-timing implication: this is not a confirmed bottom. A patient buyer waits for either an RSI cross back above ~40-45 with price reclaiming the 20-day, or a flush toward the $72.78 low where the risk/reward to a $90 fair value is much cleaner. Buying here is defensible but you are catching a falling knife.

• Rate path and asset sensitivity: WFC is asset-sensitive and benefits from elevated rates, but rising deposit costs are the offset - net interest margin mechanics are exactly why KBW cut its target to $90 in October 2026. Full-year 2026 NII guidance sits near $50B with Q4 guided to ~$13B.
• Bank regulation: anticipated changes to the Federal Reserve's annual stress tests are expected to cut capital-requirement volatility by roughly 50%, giving WFC (still climbing out of the post-asset-cap era) much clearer multi-year capital planning and buyback visibility.
• Credit cycle: steady employment and positive consumer spending support the current book, but consumer credit normalization, elevated rates and commercial real estate exposure remain the swing factors for provisions.
• Sector rotation and the yield curve: bank multiples trade off curve shape and rate-cut expectations; a steeper curve helps NIM, while an aggressive easing cycle compresses the spread WFC earns on its asset-sensitive book.
• Fintech/blockchain competition: management announced digital tokenized deposits and participation in a cross-institution stablecoin venture for H1 2027 - both a competitive hedge and a potential new revenue line.

• Progress toward the 17-18% medium-term ROTCE target - Q3 2026 already hit 16.3%, so each quarter of improvement narrows the gap and supports a P/B re-rating from 1.35x.
• Confirmation of Q4 2026 NII near $13B and the ~$50B full-year guide; any upward revision to NII would directly address the revenue-miss narrative that sold the stock off on 2026-10-13.
• Federal Reserve stress-test framework changes reducing capital volatility, which could free up incremental buyback and dividend capacity.
• Deployment of tokenized deposits and the cross-institution stablecoin venture in H1 2027, plus continued balance-sheet optimization in the post-asset-cap era.
• Ongoing buybacks: share count is already shrinking equity from $185.7B (Q4 2023) to $175.8B (Q3 2026), which compounds EPS even on flat net income.

• Revenue growth is decelerating (+4.2% YoY in Q3 2026 after +11.3% in Q2 2026) and the Q3 2026 top line missed consensus - NII guidance is essentially flat at ~$50B, so the earnings growth is leaning heavily on buybacks and expense control rather than organic revenue.
• Net interest margin compression from rising deposit costs against an asset-sensitive balance sheet; this is the specific mechanism that prompted a target cut to $90 in October 2026.
• Credit deterioration: consumer credit normalization and commercial real estate exposure could force provisions higher, which would hit the 21.3% operating margin reported in Q3 2026.
• ROE optics: common equity fell while assets grew 16.7% over three years, meaning part of the return-on-equity improvement is balance-sheet shrinkage rather than core profitability.
• Regulatory and legal overhang from the long asset-cap era has not fully cleared, and any renewed consent-order or enforcement news would hit the multiple.
• Rate-path sensitivity in the other direction: a rapid easing cycle would squeeze the asset-sensitive book while deposit costs reset more slowly.

WFC is a fundamentally improving franchise trading at a modest discount, with a weak tape and no near-term catalyst. The good parts are real: 16.3% ROTCE against a 17-18% target, EPS compounding in the low-to-mid teens year over year for four straight quarters, 10.9x trailing and ~10.7x forward earnings versus a 12.05x five-year average, a 2.12% dividend, and a clearer regulatory runway as stress-test volatility comes down. The parts that argue for patience are equally real: revenue grew just 4.2% YoY in Q3 2026 and missed consensus, NII is guided roughly flat, deposits cost more each quarter, and the stock is below all three major moving averages with an 11% one-month drawdown. For a long-term investor, accumulating a 10.7x-earnings bank with a 2%+ yield and improving returns is a reasonable use of capital; for anyone trying to time the next several weeks, there is no confirmed bottom and no dated catalyst. This is a slow compounder, not a setup.

I applied a ~12.2x justified P/E to a blended forward EPS of ~$7.40 (roughly $7.47 for FY2026E based on $5.47 of actuals through three quarters plus ~$2.00 in Q4, blended with the $7.329 FMP next-FY consensus), yielding ~$90; the multiple is set just above the 12.05x five-year average to reflect improving ROTCE and reduced regulatory capital volatility, but not at a premium given ~4% revenue growth. I cross-checked with a justified P/B of ~1.55x on ~$58.1 book value per share (equity of $175.76B over ~3,024M shares, using ROE of 11.8%, ~4.5% growth and ~9.5% cost of equity), which also lands at ~$90.